ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $237,000 | +33.1% | 1,372 | -2.5% | 0.01% | +25.0% |
| Q2 2021 | $178,000 | -7.3% | 1,407 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $192,000 | +23.1% | 1,413 | +15.6% | 0.00% | -33.3% |
| Q4 2020 | $156,000 | +32.2% | 1,222 | +15.0% | 0.01% | -14.3% |
| Q3 2020 | $118,000 | – | 1,063 | – | 0.01% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 21 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 15 | -53.1% | 0.00% | – |
| Q4 2015 | $2,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |